Work

Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

Year: 2010

Type: article

Study design: Clinical Trial

Source: Clinical Breast Cancer

DOI: 10.3816/cbc.2010.n.061

Authors: William J. Irvin, Robert Z. Orlowski, Wing-Keung Chiu, Lisa A. Carey, Frances A. Collichio, Philip S. Bernard, Inge J. Stijleman, Charles Perou, Anastasia Ivanova, E. Claire Dees

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, Huntsman Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Johnson and Johnson, National Cancer Institute, National Center for Research Resources, NIH Clinical Center

Awards: G1569999668, G251702431, G2815350159, UNC Oncology K12, G4720334866, G488872913

OpenAlex ID: W2127688249

FWCI: 0.632

Cites: 57

Cited by: 30

Related to: 10